Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchCurcuminCurcumin (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19

Kritis et al., Metabolism Open, doi:10.1016/j.metop.2020.100066
Nov 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Curcumin for COVID-19
15th treatment shown to reduce risk in February 2021, now with p = 0.0000000096 from 27 studies.
No treatment is 100% effective. Protocols combine treatments.
5,300+ studies for 116 treatments. c19early.org
Review of the potential benefits of bromelain and curcumin for COVID-19, and potential synergistic effects of the combination.
Reviews covering curcumin for COVID-19 include1-15.
Kritis et al., 13 Nov 2020, peer-reviewed, 4 authors.
This PaperCurcuminAll
Abstract: Metabolism Open 8 (2020) 100066 Contents lists available at ScienceDirect Metabolism Open journal homepage: www.journals.elsevier.com/metabolism-open The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19 Panagiotis Kritis a, 1, Irene Karampela b, *, 1, Styliani Kokoris c, Maria Dalamaga d a Pulmonary and Tuberculous Diseases Private Practice, 27 K. Aitolou, 14121, Neo Iraklio, Athens, Greece Second Department of Critical Care, Attikon General University Hospital, School of Medicine, National and Kapodistrian University of Athens, 1 Rimini Street, 12462, Haidari, Greece c Laboratory of Hematology and Blood Bank Unit, Attikon General University Hospital, School of Medicine, National and Kapodistrian University of Athens, 1 Rimini Street, 12462, Haidari, Greece d Department of Biological Chemistry, School of Medicine, National and Kapodistrian University of Athens, 27 Mikras Asias, 11527, Goudi, Athens, Greece b a r t i c l e i n f o a b s t r a c t Article history: Received 10 November 2020 Accepted 11 November 2020 Available online 13 November 2020 The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, while no treatment has been proven effective. COVID-19 pathophysiology involves the activation of three main pathways: the inflammatory, the coagulation and the bradykinin cascades. Here, we highlight for the first time the joint potential therapeutic role of bromelain and curcumin, two well-known nutraceuticals, in the prevention of severe COVID-19. Bromelain (a cysteine protease isolated from the pineapple stem) and curcumin (a natural phenol found in turmeric) exert important immunomodulatory actions interfering in the crucial steps of COVID-19 pathophysiology. Their anti-inflammatory properties include inhibition of transcription factors and subsequent downregulation of proinflammatory mediators. They also present fibrinolytic and anticoagulant properties. Additionally, bromelain inhibits cyclooxygenase and modulates prostaglandins and thromboxane, affecting both inflammation and coagulation, and also hydrolyzes bradykinin. Interestingly, curcumin has been shown in silico studies to prevent entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into cells as well as viral replication, while a recent experimental study has demonstrated that bromelain may also inhibit viral entry into cells. Notably, bromelain substantially increases the absorption of curcumin after oral administration. To the best of our knowledge, this is the first report highlighting the significance of bromelain and, most importantly, the potential preventive value of the synergistic effects of bromelain and curcumin against severe COVID-19. © 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Keywords: Bromelain COVID-19 Curcumin Nutraceuticals SARS-CoV-2 The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been devastating so far, affecting more than 45 million people and causing more than 1 million deaths globally, as of November 2, 2020 [1]. Research efforts in the quest for an effective treatment for the coronavirus disease 2019 (COVID-19) have been fruitless, while our hopes to contain the Abbreviations: ACE2, angiotensin-converting enzyme 2; COVID-19, coronavirus disease 2019; COX-2, cyclooxygenase-2; NF-kB, nuclear..
DOI record: { "DOI": "10.1016/j.metop.2020.100066", "ISSN": [ "2589-9368" ], "URL": "http://dx.doi.org/10.1016/j.metop.2020.100066", "alternative-id": [ "S2589936820300463" ], "article-number": "100066", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19" }, { "label": "Journal Title", "name": "journaltitle", "value": "Metabolism Open" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.metop.2020.100066" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2020 The Authors. Published by Elsevier Inc." } ], "author": [ { "ORCID": "http://orcid.org/0000-0001-6474-0524", "affiliation": [], "authenticated-orcid": false, "family": "Kritis", "given": "Panagiotis", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0001-6912-4042", "affiliation": [], "authenticated-orcid": false, "family": "Karampela", "given": "Irene", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-1635-7309", "affiliation": [], "authenticated-orcid": false, "family": "Kokoris", "given": "Styliani", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-7008-388X", "affiliation": [], "authenticated-orcid": false, "family": "Dalamaga", "given": "Maria", "sequence": "additional" } ], "container-title": "Metabolism Open", "container-title-short": "Metabolism Open", "content-domain": { "crossmark-restriction": true, "domain": [ "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2020, 11, 13 ] ], "date-time": "2020-11-13T06:34:17Z", "timestamp": 1605249257000 }, "deposited": { "date-parts": [ [ 2020, 12, 21 ] ], "date-time": "2020-12-21T14:58:07Z", "timestamp": 1608562687000 }, "indexed": { "date-parts": [ [ 2024, 1, 2 ] ], "date-time": "2024-01-02T07:21:24Z", "timestamp": 1704180084965 }, "is-referenced-by-count": 37, "issued": { "date-parts": [ [ 2020, 12 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 12, 1 ] ], "date-time": "2020-12-01T00:00:00Z", "timestamp": 1606780800000 } }, { "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 11, 11 ] ], "date-time": "2020-11-11T00:00:00Z", "timestamp": 1605052800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S2589936820300463?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S2589936820300463?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "100066", "prefix": "10.1016", "published": { "date-parts": [ [ 2020, 12 ] ] }, "published-print": { "date-parts": [ [ 2020, 12 ] ] }, "publisher": "Elsevier BV", "reference": [ { "author": "Worldometer", "key": "10.1016/j.metop.2020.100066_bib1" }, { "DOI": "10.1001/jama.2020.12839", "article-title": "Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review", "author": "Wiersinga", "doi-asserted-by": "crossref", "first-page": "782", "issue": "8", "journal-title": "J Am Med Assoc", "key": "10.1016/j.metop.2020.100066_bib2", "volume": "324", "year": "2020" }, { "DOI": "10.3389/fimmu.2020.02014", "article-title": "Understanding the pathophysiology of COVID-19: could the contact system Be the key?", "author": "Meini", "doi-asserted-by": "crossref", "first-page": "2014", "journal-title": "Front Immunol", "key": "10.1016/j.metop.2020.100066_bib3", "volume": "11", "year": "2020" }, { "DOI": "10.1016/j.ejphar.2020.173551", "article-title": "Curcumin, a traditional spice component, can hold the promise against COVID-19?", "author": "Soni", "doi-asserted-by": "crossref", "first-page": "173551", "journal-title": "Eur J Pharmacol", "key": "10.1016/j.metop.2020.100066_bib4", "volume": "886", "year": "2020" }, { "DOI": "10.3892/br.2016.720", "article-title": "Potential role of bromelain in clinical and therapeutic applications", "author": "Rathnavelu", "doi-asserted-by": "crossref", "first-page": "283", "issue": "3", "journal-title": "Biomed Rep", "key": "10.1016/j.metop.2020.100066_bib5", "volume": "5", "year": "2016" }, { "DOI": "10.4143/crt.2014.46.1.2", "article-title": "Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice", "author": "Prasad", "doi-asserted-by": "crossref", "first-page": "2", "issue": "1", "journal-title": "Cancer Res Treat", "key": "10.1016/j.metop.2020.100066_bib6", "volume": "46", "year": "2014" }, { "DOI": "10.1111/irv.12459", "article-title": "Curcumin alleviates macrophage activation and lung inflammation induced by influenza virus infection through inhibiting the NF-κB signaling pathway", "author": "Xu", "doi-asserted-by": "crossref", "first-page": "457", "issue": "5", "journal-title": "Influenza Other Respir Viruses", "key": "10.1016/j.metop.2020.100066_bib7", "volume": "11", "year": "2017" }, { "DOI": "10.3389/fmicb.2019.00912", "article-title": "Anti-infective properties of the golden spice curcumin", "author": "Praditya", "doi-asserted-by": "crossref", "first-page": "912", "journal-title": "Front Microbiol", "key": "10.1016/j.metop.2020.100066_bib8", "volume": "10", "year": "2019" }, { "article-title": "The cysteine proteinases of the pineapple plant", "author": "Rowan", "first-page": "869", "issue": "3", "journal-title": "Biochem J", "key": "10.1016/j.metop.2020.100066_bib9", "volume": "266", "year": "1990" }, { "DOI": "10.1016/j.canlet.2009.03.003", "article-title": "Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway", "author": "Bhui", "doi-asserted-by": "crossref", "first-page": "167", "issue": "2", "journal-title": "Canc Lett", "key": "10.1016/j.metop.2020.100066_bib10", "volume": "282", "year": "2009" }, { "article-title": "Properties and therapeutic application of bromelain: a review", "author": "Pavan", "first-page": "976203", "journal-title": "Biotechnol Res Int", "key": "10.1016/j.metop.2020.100066_bib11", "year": "2012" }, { "article-title": "Nutritional and botanical modulation of the inflammatory cascade--eicosanoids, cyclooxygenases, and lipoxygenases--as an adjunct in cancer therapy", "author": "Wallace", "first-page": "7", "issue": "1", "journal-title": "Integr Canc Ther", "key": "10.1016/j.metop.2020.100066_bib12", "volume": "1", "year": "2002" }, { "DOI": "10.1016/j.clim.2007.11.002", "article-title": "Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro", "author": "Onken", "doi-asserted-by": "crossref", "first-page": "345", "issue": "3", "journal-title": "Clin Immunol", "key": "10.1016/j.metop.2020.100066_bib13", "volume": "126", "year": "2008" }, { "DOI": "10.1006/cimm.2001.1807", "article-title": "Bromelain modulates T cell and B cell immune responses in vitro and in vivo", "author": "Engwerda", "doi-asserted-by": "crossref", "first-page": "66", "issue": "1", "journal-title": "Cell Immunol", "key": "10.1016/j.metop.2020.100066_bib14", "volume": "210", "year": "2001" }, { "DOI": "10.1055/s-2006-960949", "article-title": "On the pharmacology of bromelain: an update with special regard to animal studies on dose-dependent effects", "author": "Lotz-Winter", "doi-asserted-by": "crossref", "first-page": "249", "issue": "3", "journal-title": "Planta Med", "key": "10.1016/j.metop.2020.100066_bib15", "volume": "56", "year": "1990" }, { "DOI": "10.1016/0378-8741(88)90127-4", "article-title": "Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update", "author": "Taussig", "doi-asserted-by": "crossref", "first-page": "191", "issue": "2", "journal-title": "J Ethnopharmacol", "key": "10.1016/j.metop.2020.100066_bib16", "volume": "22", "year": "1988" }, { "author": "Sagar", "key": "10.1016/j.metop.2020.100066_bib17", "series-title": "Bromelain inhibits SARS-CoV-2 infection in VeroE6 cells", "year": "2020" } ], "reference-count": 17, "references-count": 17, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S2589936820300463" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "General Medicine" ], "subtitle": [], "title": "The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "8" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit